|« Previous month||Next month »|
23-Dec-2009 - US investment group Kansas Venture Capital (KVC) has acquired ZeeCRO’s bioanalytical division.
23-Dec-2009 - US CRO Pacific Biometrics is to be renamed Pacific Biomarkers, after shareholders voted in favour of the change at the company’s AGM earlier this month.
23-Dec-2009 - NYK Logistics will be responsible for all the distribution of all the products that Ranbaxy Laboratories, the non-branded arm of Japanese pharmaceutical firm DaiChii-Sankyo, sells in the UK under a...
23-Dec-2009 - Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including changes at SRC, Pacific Biometrics, GVK Biosciences and DPT Laboratories.
22-Dec-2009 - Patheon says a slowdown in “outsourcing decision making,” manufacturing problems in Puerto Rico and cost related to JLL’s takeover bid hurt it in fiscal 09.
22-Dec-2009 - The global pharmaceutical contract manufacturing sector is growing at 11 per cent a year and will generate $299bn (€209bn) by 2014, says BCC Research.
22-Dec-2009 - US CRO and discovery technology supplier XenoTech has launched CryostaX, which it claims is the largest single-freeze pool of human hepatocytes available to drug developers.
22-Dec-2009 - US genomic analysis group BioTrove has completed the spin out of Biocius Life Sciences, a new contract drug discovery company.
21-Dec-2009 - Trials contractor Kendle International will use a management platform developed by US software group MetricStream to help control its global compliance and quality assurance operations.
21-Dec-2009 - US CRO PPD will add a database of 16,000 patients to its portfolio in an exclusive services deal with Houston-based care organisation DiabetesAmerica.
21-Dec-2009 - Jubilant Organosys will build a new niacinamide and 3-Cyanopyridine plant to cater for growing demand in the drug and nutrition industries.
21-Dec-2009 - US drugmaker NexMed has maintained its place on the Nasdaq Stock Exchange, partly as a result of its acquisition of US preclinical CRO Bio-Quant.
17-Dec-2009 - Swedish CDMO Recipharm will buy privately-owned group Cobra Biomanufacturing to build its presence in the expanding biologics sector.
17-Dec-2009 - NextPharma unveiled plans for a new cold chain and logistics unit earlier today to bolster its European distribution operations.
17-Dec-2009 - US CRO Covance says its new development offices in South Korea and India will improve access to patients and reduce clinical development timelines.
16-Dec-2009 - US eClinical firm Phase Forward has created the new executive role, “chief privacy officer,” to ensure it complies with the latest data protection and privacy regulations governing the trial sector.
16-Dec-2009 - US software firm Instem will establish an office in Shanghai, China, to provide customer support, client management, development and sales support to its Chinese pharmaceutical and life sciences R&D clients....
16-Dec-2009 - CRO Icon says the expansion of its central lab facility in Dublin, Ireland will provide better support for its clinical investigators worldwide.
15-Dec-2009 - US formulation services provider Bend Research says a new safety file for the bioavailability enhancing drug excipient, HPMCAS, can now be referenced by its clients in FDA filings.
15-Dec-2009 - Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Absorption Systems, CliniComp, Clearstone Central Laboratories and CTI.
15-Dec-2009 - US software giant Microsoft has unveiled plans to acquire Sentillion to further expand its presence in the clinical data management sector.
15-Dec-2009 - US drug discovery group Deltagen has acquired Benten BioServices, a contract services organisation that offers a suite of regulatory-compliant manufacturing and testing services to support biopharmaceutical development and commercialisation.
14-Dec-2009 - Netherlands-based contract research group TNO has purchased an accelerator mass spectrometer (AMS) to add microdosing to its clinical trial offering.
14-Dec-2009 - CMO Avid Bioservices’ year-on-year revenues increased by 440 per cent in the second quarter, leading to the company planning expansions in Asia-Pacific, biosimilars and analytical services.
|« Previous month||Next month »|